Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Bullboard Posts
Comment by lv_426on Apr 08, 2020 5:43pm
81 Views
Post# 30892010

RE:Missed Opportunities

RE:Missed Opportunities
Ingiboy wrote: As Replicel drifts into "sleeper mode" I look at the missed trading opportunities happening right now.

 Having owned this stock for close to 4 years I reflect back on what got me into this stock and what has kept me here for so long.  Initially it was the original stem cell technology and the people involved that made it look so promising.  Then it was the partnerships first with Shiseido and then Yofoto that kept me excited.  The development of an innovative Dermal Injector that would be unique in the Dermal Industry gave me hope I would see some return on my investment.
Here I am 4 years down the road with my shares trading at $.25 which is about a third of my average after averaging down numerous times.
 
Yes I am bitter.  This past week has got me particularly P.O.. I see money I have tied up here that could be better used to take advantage of opportunites especially in the Energy sector after the "blowdown" of Canadian oil and gas companies that look like they may be getting up off the mat.

I don't think there is any doubt now that the relationship between Replicel and Shiseido is permanently  broken. I am annoyed that management has not addressed this with the shareholders. It has been well over a year that we became aware there was acrimony between the two companies.  It is time to face the music and give the shareholders the facts. It if it negatively affects the share price so be it. Let's get it over with.  

We heard about Yofotos newly developed stem cell research centre close to a year ago.  Are they doing any research related to Replicel ?  It would be nice to know.

We hear about potential new partners in Japan an potential distributors of the Dermal Injector ?  We have been hearing this for far too long without results.

Yes I am "pissed" and to be honest I am very close to selling these P.O.S. shares at $.25 and putting the feeble amount of money it generates into something that may go up.


Not sure what the level 2 looks like but if you do sell it would definitely tank the stock
Bullboard Posts